Osteopore Past Earnings Performance

Past criteria checks 0/6

Osteopore's earnings have been declining at an average annual rate of -26.4%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 19.3% per year.

Key information

-26.4%

Earnings growth rate

134.2%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate19.3%
Return on equity-1,126.2%
Net Margin-219.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Osteopore makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:OSXDA Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 232-552
30 Sep 232-560
30 Jun 232-570
31 Mar 232-560
31 Dec 222-460
30 Sep 222-451
30 Jun 221-441
31 Mar 221-450
31 Dec 211-450
30 Sep 211-340
30 Jun 211-340
31 Mar 211-240
31 Dec 202-240
30 Sep 201-230
30 Jun 201-230
31 Mar 201-230
31 Dec 190-230
31 Dec 181-120
31 Dec 171010
31 Dec 160-110

Quality Earnings: OSXDA is currently unprofitable.

Growing Profit Margin: OSXDA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OSXDA is unprofitable, and losses have increased over the past 5 years at a rate of 26.4% per year.

Accelerating Growth: Unable to compare OSXDA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSXDA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: OSXDA has a negative Return on Equity (-1126.2%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies